Conmed Corp (CNMD)

R&D Expenses

$15.50M

Quarterly · Period ending: · USD

CNMD logo

CNMD R&D Expenses

Latest reported$15.50M
CNMD Quarterly R&D Expenses ($0.00 → $15.50M)
High-resolution chart · PNG

CNMD r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Conmed Corp R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
15,500,000
16,333,000
14,899,000
13,901,000
14,138,000
12,947,000
13,176,000
13,558,000
14,098,000
13,594,000
14,028,000
12,464,000
13,572,000
12,539,000
12,220,000
12,767,000
11,493,000
10,672,000
11,362,000
10,859,000
11,318,000
10,027,000
11,717,000
9,936,000
8,700,000
10,120,000
12,094,000
10,985,000
11,806,000
10,575,000
10,371,000
14,122,000
9,985,000
7,711,000
8,378,000
8,270,000
8,041,000
7,618,000
7,634,000
8,353,000
8,009,000
8,258,000
6,741,000
6,652,000
7,501,000
6,542,000
7,105,000
6,910,000
6,854,000
6,910,000
6,438,000
7,108,000
6,591,000
5,694,000
6,850,000
7,077,000
7,192,000
7,095,000
7,152,000
7,021,000
6,797,000
7,681,000
8,130,000
7,399,000
6,441,000
7,682,000
8,247,000
7,705,000
7,396,000
8,489,000
7,673,000
8,668,000
8,689,000
8,078,000
7,417,000
7,936,000
7,453,000
7,594,000
8,130,000
7,262,000
7,498,000
7,825,000
6,836,000
6,409,000
6,375,000
5,849,000
5,924,000
4,706,000
4,836,000
4,739,000
4,738,000
4,487,000
4,378,000
3,703,000
3,932,000
4,253,000
4,078,000
3,824,000
4,167,000
3,491,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.